Risalto Health Inc.

Risalto Health Inc. specializes in digital health solutions that enhance medical management strategies for health plans and patients, focusing on pain management through digital therapy and coaching. Founded in 2016 and headquartered in New York, US, Risalto Health Inc. provides digital health solutions aimed at optimizing pain management strategies.

The company has completed 2 deals, with its most recent funding round date being October 13, 2019, when it raised USD 7 mn from Health Catalyst Capital Management and Oxeon Partners. The CEO and founder, Dan Pizzarello, leads the firm in delivering innovative healthcare solutions. Risalto Health offers a comprehensive suite of digital health solutions aimed at optimizing medical management strategies for health plans, providers, and patients. Their primary offerings focus on addressing pain management for back, neck, shoulder, knee, and hip conditions through digital therapy and personal coaching.

These services are designed to empower patients by providing them with tools and resources to manage pain effectively, thereby reducing the need for unnecessary surgeries and improving overall patient outcomes. The platform leverages independent experts and the latest evidence to guide patients in choosing the most appropriate care pathways. Risalto Health primarily serves health plans, healthcare providers, and individual patients in the United States, aiming to enhance the efficiency of healthcare delivery while delighting members and reducing overall costs. Risalto Health's revenue model centers around partnerships with health plans and healthcare providers, enabling the company to offer its services through subscription-based arrangements.

These partnerships facilitate direct access to Risalto's digital health solutions for providers and their patients, fostering a streamlined integration into existing healthcare frameworks. The transaction structure includes recurring fees associated with ongoing access to their digital tools, enabling healthcare organizations to scale the usage of Risalto's platform across their patient populations. Specific pricing plans for their services are structured to accommodate various client needs, enhancing accessibility while maintaining a focus on delivering high-quality care pathways. The company's commitment to evidence-based practices and patient empowerment positions it favorably within the healthcare market, underscoring its potential as a valuable partner for healthcare organizations.

In November 2019, Risalto Health Inc. raised USD 7 mn in venture funding to support its future initiatives. The company plans to develop new products aimed at enhancing patient engagement in pain management and expects to launch these products by 2022. Additionally, Risalto Health is exploring expansion into new markets, specifically targeting healthcare providers in the Midwest and Southeast regions of the United States by the end of 2023.